Timothy L Swan, MD | |
1000 N Oak Ave, Marshfield, WI 54449-5703 | |
(715) 389-3555 | |
Not Available |
Full Name | Timothy L Swan |
---|---|
Gender | Male |
Speciality | Interventional Radiology |
Experience | 35 Years |
Location | 1000 N Oak Ave, Marshfield, Wisconsin |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346340668 | NPI | - | NPPES |
32029600 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 35286 (Wisconsin) | Secondary |
2085R0204X | Radiology - Vascular & Interventional Radiology | 35286 (Wisconsin) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Marshfield Medical Center | Marshfield, WI | Hospital |
Lakeview Medical Center Of Rice Lake | Rice lake, WI | Hospital |
Ascension St Clares Hospital | Weston, WI | Hospital |
Marshfield Medical Center - Eau Claire | Eau claire, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Marshfield Clinic Inc | 2264345206 | 99 |
Mchs Hospitals Inc | 5698071173 | 1049 |
News Archive
The cause of heart attacks or strokes among some patients treated with anti-platelet drugs may be different than for patients who have undergone surgical procedures to restore blood flow, according to researchers at Duke Medicine.
Improved tools are now underway for determining the causes of death in settings where medical examinations or post-mortem autopsies are not routinely conducted.
ImmunoCellular Therapeutics, Ltd. announced that the US Food and Drug Administration (FDA) has allowed the investigational new drug (IND) application for ICT-140, paving the way for conducting a clinical trial.
Drugs for brain diseases such as Alzheimer's, Parkinson's, and motor neurone disease that have stalled in development could be revived thanks to the efforts of a global coalition of non-profit organizations and funders announced today.
› Verified 6 days ago
Entity Name | Marshfield Clinic Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952347981 PECOS PAC ID: 2264345206 Enrollment ID: O20031106000590 |
News Archive
The cause of heart attacks or strokes among some patients treated with anti-platelet drugs may be different than for patients who have undergone surgical procedures to restore blood flow, according to researchers at Duke Medicine.
Improved tools are now underway for determining the causes of death in settings where medical examinations or post-mortem autopsies are not routinely conducted.
ImmunoCellular Therapeutics, Ltd. announced that the US Food and Drug Administration (FDA) has allowed the investigational new drug (IND) application for ICT-140, paving the way for conducting a clinical trial.
Drugs for brain diseases such as Alzheimer's, Parkinson's, and motor neurone disease that have stalled in development could be revived thanks to the efforts of a global coalition of non-profit organizations and funders announced today.
› Verified 6 days ago
Entity Name | Memorial Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346239373 PECOS PAC ID: 2365433224 Enrollment ID: O20040519001426 |
News Archive
The cause of heart attacks or strokes among some patients treated with anti-platelet drugs may be different than for patients who have undergone surgical procedures to restore blood flow, according to researchers at Duke Medicine.
Improved tools are now underway for determining the causes of death in settings where medical examinations or post-mortem autopsies are not routinely conducted.
ImmunoCellular Therapeutics, Ltd. announced that the US Food and Drug Administration (FDA) has allowed the investigational new drug (IND) application for ICT-140, paving the way for conducting a clinical trial.
Drugs for brain diseases such as Alzheimer's, Parkinson's, and motor neurone disease that have stalled in development could be revived thanks to the efforts of a global coalition of non-profit organizations and funders announced today.
› Verified 6 days ago
Entity Name | Memorial Hospital Inc |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1346239373 PECOS PAC ID: 2365433224 Enrollment ID: O20110526000807 |
News Archive
The cause of heart attacks or strokes among some patients treated with anti-platelet drugs may be different than for patients who have undergone surgical procedures to restore blood flow, according to researchers at Duke Medicine.
Improved tools are now underway for determining the causes of death in settings where medical examinations or post-mortem autopsies are not routinely conducted.
ImmunoCellular Therapeutics, Ltd. announced that the US Food and Drug Administration (FDA) has allowed the investigational new drug (IND) application for ICT-140, paving the way for conducting a clinical trial.
Drugs for brain diseases such as Alzheimer's, Parkinson's, and motor neurone disease that have stalled in development could be revived thanks to the efforts of a global coalition of non-profit organizations and funders announced today.
› Verified 6 days ago
Entity Name | Mchs Hospitals Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093221434 PECOS PAC ID: 5698071173 Enrollment ID: O20180208000096 |
News Archive
The cause of heart attacks or strokes among some patients treated with anti-platelet drugs may be different than for patients who have undergone surgical procedures to restore blood flow, according to researchers at Duke Medicine.
Improved tools are now underway for determining the causes of death in settings where medical examinations or post-mortem autopsies are not routinely conducted.
ImmunoCellular Therapeutics, Ltd. announced that the US Food and Drug Administration (FDA) has allowed the investigational new drug (IND) application for ICT-140, paving the way for conducting a clinical trial.
Drugs for brain diseases such as Alzheimer's, Parkinson's, and motor neurone disease that have stalled in development could be revived thanks to the efforts of a global coalition of non-profit organizations and funders announced today.
› Verified 6 days ago
Entity Name | Lakeview Medical Center Inc Of Rice Lake |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093201832 PECOS PAC ID: 6103737820 Enrollment ID: O20180817001484 |
News Archive
The cause of heart attacks or strokes among some patients treated with anti-platelet drugs may be different than for patients who have undergone surgical procedures to restore blood flow, according to researchers at Duke Medicine.
Improved tools are now underway for determining the causes of death in settings where medical examinations or post-mortem autopsies are not routinely conducted.
ImmunoCellular Therapeutics, Ltd. announced that the US Food and Drug Administration (FDA) has allowed the investigational new drug (IND) application for ICT-140, paving the way for conducting a clinical trial.
Drugs for brain diseases such as Alzheimer's, Parkinson's, and motor neurone disease that have stalled in development could be revived thanks to the efforts of a global coalition of non-profit organizations and funders announced today.
› Verified 6 days ago
Entity Name | Mchs Hospitals Inc |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1952890873 PECOS PAC ID: 5698071173 Enrollment ID: O20180904002962 |
News Archive
The cause of heart attacks or strokes among some patients treated with anti-platelet drugs may be different than for patients who have undergone surgical procedures to restore blood flow, according to researchers at Duke Medicine.
Improved tools are now underway for determining the causes of death in settings where medical examinations or post-mortem autopsies are not routinely conducted.
ImmunoCellular Therapeutics, Ltd. announced that the US Food and Drug Administration (FDA) has allowed the investigational new drug (IND) application for ICT-140, paving the way for conducting a clinical trial.
Drugs for brain diseases such as Alzheimer's, Parkinson's, and motor neurone disease that have stalled in development could be revived thanks to the efforts of a global coalition of non-profit organizations and funders announced today.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Timothy L Swan, MD 1000 N Oak Ave, Marshfield, WI 54449-5703 Ph: () - | Timothy L Swan, MD 1000 N Oak Ave, Marshfield, WI 54449-5703 Ph: (715) 389-3555 |
News Archive
The cause of heart attacks or strokes among some patients treated with anti-platelet drugs may be different than for patients who have undergone surgical procedures to restore blood flow, according to researchers at Duke Medicine.
Improved tools are now underway for determining the causes of death in settings where medical examinations or post-mortem autopsies are not routinely conducted.
ImmunoCellular Therapeutics, Ltd. announced that the US Food and Drug Administration (FDA) has allowed the investigational new drug (IND) application for ICT-140, paving the way for conducting a clinical trial.
Drugs for brain diseases such as Alzheimer's, Parkinson's, and motor neurone disease that have stalled in development could be revived thanks to the efforts of a global coalition of non-profit organizations and funders announced today.
› Verified 6 days ago
Kristin M Gerndt, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-389-3474 | |
John R Sheflin, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-389-3555 | |
Anderson A Bauer, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 414-517-5877 | |
Anthony H Devries, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 866-520-2510 | |
Lawrence G Hutchins, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-389-3555 | |
William F Manor, DO Radiology Medicare: Not Enrolled in Medicare Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-389-3555 | |
Nandita R Bhattacharjee, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 313 N Schmidt Ave, Marshfield, WI 54449 Phone: 715-389-9200 |